Literature DB >> 1735599

Potent constrictor actions of endothelin-1, endothelin-2, and endothelin-3 in rat isolated portal vein.

C L Guimarães1, J B Calixto, G A Rae.   

Abstract

In rings of rat portal vein, endothelin-1, endothelin-2, and endothelin-3 caused graded slow contractions and potentiated spontaneous contractions. The apparent EC50 values and maximal responses to 30 nM endothelin were 1.4 nM and 0.96 g for endothelin-1, 5.2 nM and 0.65 g for endothelin-2, and 1.7 nM and 0.62 g for endothelin-3 (n = 4-12). At concentrations producing half the contraction triggered by 80 mM KCl, the order of potencies was endothelin-1 greater than U46619 = angiotensin II greater than bradykinin greater than substance P greater than phenylephrine. Longitudinal portal-mesenteric vein preparations developed very modest contractions to endothelin-1 (0.13 g at 30 nM; n = 5), but their responses to 80 mM KCl and phenylephrine were greater than those of rings. Responses of rings to endothelin-1 were profoundly reduced in Ca(2+)-free medium, but less inhibition was obtained after incubation with nicardipine (up to 1 microM) and/or nickel (up to 0.5 mM), phorbol (up to 0.3 microM), staurosporine (up to 10 nM), or cromakalim (3 microM). Indomethacin (5.6 microM) did not affect responses to endothelin-1. Cromakalim (0.1-3 microM) also relaxed rings constricted with 0.3 nM endothelin-1, and this effect was partially reversed by glibenclamide (3 microM). Thus, endothelins, especially endothelin-1, are potent constrictors of portal vein rings but not of portal-mesenteric vein strips. Their action appears to rely largely on Ca2+ influx from the external medium (only in part via L- and T-type Ca2+ channels) and activation of protein kinase C but not on eicosanoid generation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1735599     DOI: 10.1161/01.hyp.19.2_suppl.ii79

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer.

Authors:  Lowell Ling; Janet J Maguire; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

2.  Endothelin-1 levels in portal venous blood in relation to hepatic tissue microcirculation disturbance and hepatic cell injury after ischemia/reperfusion.

Authors:  T Ota; R Hirai; A Urakami; H Soga; S Nawa; N Shimizu
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Loss of function of endothelin-2 leads to reduced ovulation and CL formation.

Authors:  Joseph A Cacioppo; Sang Wook Oh; Hey-young Kim; Jongki Cho; Po-Ching Patrick Lin; Masashi Yanagisawa; CheMyong Ko
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

Review 4.  Endothelin.

Authors:  Anthony P Davenport; Kelly A Hyndman; Neeraj Dhaun; Christopher Southan; Donald E Kohan; Jennifer S Pollock; David M Pollock; David J Webb; Janet J Maguire
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

5.  Differential genetic basis for pre-menopausal and post-menopausal salt-sensitive hypertension.

Authors:  Victoria L M Herrera; Khristine A Pasion; Ann Marie Moran; Nelson Ruiz-Opazo
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

6.  Dahl (S x R) congenic strain analysis confirms and defines a chromosome 5 female-specific blood pressure quantitative trait locus to <7 Mbp.

Authors:  Victoria L M Herrera; Khristine A Pasion; Ann Marie Moran; Nelson Ruiz-Opazo
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.